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Introduction 
The Convention on Biological Diversity (CBD) defines Biotechnology as : 
"any technological application that uses biological systems, living organisms, or derivatives 
thereof, to make or modify products or processes for specific use". According to Dr. Rita 
Colwell, Director, National Science Foundation, USA, the apt definition is • making money 
from Biologyn. Biotechnology involves application of scientific and engineering principles to 
provide goods and services through mediation of biological agents. Traditional application 
includes antibiotic production through fermentation, microbial sewage treatment and water 
purification. Modem molecular biotechnology involves gene manipulation and gene transfer, 
DNA typing, bacterial cloning for production of biomolecules etc. 
In 1992, an Organization of Economic Co-operation and Development report on 
biotechnology defined marine biotechnology as "the application of scientific and engineering 
principles to the processing of materials by marine biological agents to provide goods and 
services." This would include biotechnology-based methods for aquaculture, fisheries, and 
marine natural products. Marine biotechnology is gaining momentum due to its vast potential 
application in augmenting seafood production, safeguarding human health, protecting and 
restoring aquatic environment (bioremediation), reducing fouling and corrOSion, exploiting 
ma~ne natural products for human benefit, conserving biodiversity, managing fish and 
shellfish resources and in clarifying fish and shellfish species status. 
The gene pool and biological processes of large majority of marine organisms 
including microorganisms are not known well enough. However, exploratory research shows 
the potential for exploiting the biochemical capabilities of marine organism to provide models 
for new classes of pharmaceuticals, polymers, enzymes, other chemical products, industrial 
processes as well as vaccines, diagnostic and analytical reagents, genetically altered 
organisms for aquaculture and seafood industry. 
Biotechnological Interventions in Aquaculture: 
Aquaculture is receiving importance as extreme focus sector for development in view 
of its role in augmenting production of nutritious food besides a large variety of natural 
products. Recent researches have amply proved the need for biotechnological interventions 
in sustaining aquaculture production . Significant growth enhancement has been achieved 
through hormonal intervention and gene manipulation. Success stories are documented on 
biotechnological interventions in induction and control of maturation and spawning, sex 
control (gynogenesis and andrOgenesis), sex inversion in protandrous species like sea bass 
and protogynous species like the grouper, genetic improvement (production of triploids and 
tetraploids and transgenic species), in disease diagnosis (molecular and immunodiagnostic 
kits) and management (probiotics, vaccines, immunostimulants, gene therapy), cell and 
tissue culture (in vitro peart production), conservation of germ plasm (cryopreservation of 
gametes and embryos) 
Biotechnological interventions in aquafeed production include bioencapsulation of live 
feed, nutrient enrichment of raw materials (fermentation), reducing antinutrients and crude 
fibre levels, production of enzymes - o-alpha amylase, ~-amylase, cellulase / hemi-
cellulase & phytase) amino acids (I-lysine, threonine & monosodium glutamate), microbial 
polysaccharides, vitamins (B 2, B 12, Biotin), organic acids (lactic acid), flavours, growth 
promoters, carotenoids (Haematococcus, Duna/ie/la), essential fatty acids (bacteria, fungi & 
thraustochytrids) 
Genomic and genetic improvement 
The main thrust area in genetiC improvement of farmed fish and shellfish is to 
enhance desirable traits (phenotypic character) of high economic importance - growth rate, 
size at first maturity, egg number, egg size, egg weight, egg survival, larval survival, disease 
resistance, behaviour, resistance to environmental factors, dressing weight, carcass quality, 
fat content, protein content, food conversion, anatomic modification, colour and others. 
Genomics will help identify and select with precision useful genes in fish, 
invertebrates, and algae for aquaculture. Genome mapping is being carried out in a number 
of economically important aquaculture speCies. 
Production of transgenic fish by inserting desirable genes through electroporation 
and microinjection has been successfully carried out since the mid-19SOs. In a number of 
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cases, fish growth hormone genes, along with a reporter gene, which will tell whether the 
transformation is successful, are inserted into the fish. There are reports of better growth in 
transgenic tilapia, catfish, and rainbow trout than non-transgenic individuals. 
The primary goal of genomics is to identify genetic diversity within stocks and 
identify genes that can be transferred into fish or invertebrate eggs and result in transgenic 
animals with improved safety and economic benefit such as better and faster growth rates, 
disease resistance, greater toleration for environmental change (e.g., cold water tolerance), 
increased fecundity, and more edible meat and to produce pharmaceuticals. 
Biotechnology methods have resulted in production of new, genetically engineered 
vaccines for aquaculture, such as the vaccine against infectious hematopoietic necrosis (IHN) 
virus, which is responsible for the death of trout and other salmonid stock. 
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Bioactive compounds and biomolecules 
The marine bioactive compounds or marine natural products (MNPs) offer avenues 
for developing cost-effective, safe and potent new drugs and other useful products. MNPs 
are organic compounds produced by microbes, sponges, seaweeds, and other marine 
organisms. The host organism biosynthesizes these compounds as non-primary or secondary 
metabolites to protect themselves and to maintain homeostasis in their environment. In the 
decade from 19n to 1987, around 2500 new metabolites (MNPs) were reported from marine 
organisms ranging froin microbes to fish. . Perusal of literature indicates that even the 
seawater has bacteriddal properties, which is primarily attributed to the production of 
antibiotics by planktonic algae and bacteria respectively. Researches carried out globally 
resulted in identification of hundreds of free-living and symbiotic marine microorganisms 
and numerous marine invertebrates that have the potential to produce new 
pharmaceutical compounds cosmetics and neutraceuticals. 
A large variety of marine micro and macro organisms have been screened and 
some of them are found to contain anti-viral, anti-microbial and anti-inflammatory 
compounds. Micro algae are rich sources of bioactive compounds. Cyanobacteria contain 
natural compounds that also serve as models for drug development. By determining 
metabolic control mechanisms and restrictions, as well as optimizing culture media for 
production of secondary metabolites and methods for the isolation and identification of 
genes controlling secondary metabolism could help in large scale culture of important 
species. 
Bugu/a nenana, a slow growing marine bryozoan is the source of a potential 
drug, which is active against leukemia. Prostaglandins isolated from marine organisms like 
gcitgonids are found to be active against chemotherapeutically resistant ovarian cancer. 
Anti-inflammatory drugs could also be isolated from marine algae, by developing proper 
culture techniques. 
Marine organisms, many of which can be mass cultured, are sources of 
commerdal products, among which are food additives such as carrageenan, agar, and chitin; 
ccmmer(;ai £ .1'" ere "II..'; fGr dt:lE:IQtnts and for bI01u,.;<;a1 r('cgH1ts; an':: errl\..; voJucts. 
Nutraceuticals, such as food-based enhancers, and cosmetics also can be 
produced from marine sources. The soft coral, Pseudopterogorgia elisabethae, is the source 
of pseudopterosin that is used as a cosmetic additive. 
In sponges, the secondary metabolites are synthesized to protect themselves 
and to maintain homeostasis. The wider biosynthetic capability of sponges could be 
attributed to their biological association with other symbionts. A wide variety of secondary 
metabolites were isolated from sponges and these have been associated with antibacterial, 
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antimicrobial, antiviral, antifouling, HIVprotease inhibitory, HIV reverse transcriptase 
inhibitory, immune- suppressent and cytotoxic activities. In addition to potential anticancer 
applications, the MNPs of sponges have a myriad of activities ranging from antibiotic activity 
including anticoagulant, antithrombin, anti-inflammatory, as well as imunomodulatory 
activities. 
Many marine organisms have also been documented to be sources of 
prostaglandins-PG1, PG2 , and PG3, and fatty acids like docosahexaenoic, eicosapentaenoic 
and arachidonic acids, which are receiving importance in human and animal nutrition and 
health care. The sea is also the richest source of carotenoids - beta carotene, astaxanthin. 
A thermo stable alpha-galactosidase, which can hydrolyse melibiose oligomers 
in soya and other bean products, is isolated from the bacterium, Themotilga neaopo/itilna 
from oceanic blacksmokers. Enzymes extracted from Archaea thermococca/es (DNA 
polymerase having 5 times more half life) will increase effiCiency in biotechnological process 
requiring replication of DNA. Phytases are produced by a variety of bacteria and fungii. 
New mineral organiC materials could be developed from certain marine 
organisms, which consist of diatom produced biosilicate and chitin fibres. These matenals 
are biodegradable and exhibit a remarkably high strength to weight ratio and are superior to 
synthetic materials used in industry. Industrial surfactants could be manufactured from 
fish meal processing wastes. 
Environmental bioremediation 
Microbes have been successfully used in bioconversion for waste management in 
controlling pollution, detoxification of industrial organics such a PCBs, PAHs, and creosote, 
and heavy metals copper, chromium and arsenic to harmless prodUcts. Transgenic 
Cyanobacterium, Synechococcus, with the gene for mammalian metallothionein, increase its 
heavy metal resistance and accumulation 
Cyanobacteria Synechococcus and green alga Chlamydomonas reihardtu have been 
effectively used against heavy metal (cadmium) contamination by its genetic modification by 
inserting a gene for increasing its heavy metal resistance and accumulation. 
Solving fishery related problems 
Biotechnological tools can be applied in stock assessment of fish and shellfish, for 
studying genetic diversity of different marine organisms; ratification of taxonomic status of 
fish and shellfish and for identification of distinct stocks of fish and shellfish species and the 
degree to which they inter-mix 
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Biosafety and environmental issues 
Biosafety concerns raised against commercial production of transgenic fish or 
shellfish must be considered on a case-by-<:ase basis, focusing on the species, culture 
system, and ecosystem and quality of the products derived. Other major concerns are 
possible impact if the transgenic animals escape into the environment and the parental 
stocks that are genetically modified but not sterile. 
Conclusion 
Marine Biotechnology is just beginning to revolutionize our ability to better use 
marine resources ... In the US 190 patents were granted from 1983 to 1995, 30 marine 
products targeting cancer, inflammation and AIDs; the market value of 5 of the products is 
valued at 2 billion US$. One anti-inflammatory agent Pseudoterosin derived from soft corals 
has projected sales of 100 million US$. Japan has set up a network of Marine Biotechnology 
Laboratories investing more than 1 billion US $ to hamess the enonnous potential. In India 
Shanta Marine Biotech and EID Parry have already set up industries to produce astaxanthin 
from Haematococcus and beta carotene from Duna/iella. 
In the future advances in such areas as bioconversion, biomaterials, pharmaceuticals 
and diagnostics, aquaculture, seafood safety, bioremediation, and biofilms and corrosion 
would play vital roles in sustainable development programmes. Currently a multibillion dollars 
industry worldwide we can expect greater leaps in Marine Biotechnology in the future 
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